| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
24Hr HomeCare is a El Segundo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A-T Children's Project is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Frantz Medical Group is a Mentor, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our Partnership Health Centers offer customized, patient-centered, cost-effective health programs built on the wisdom of coordinated care. We believe in an effective, medical-home partnership strategy to cut the price of medical expenses by promoting better health outcomes. No one in the industry offers more services at the same location, with same-day appointments and no co-pays! We have data to prove our company motto: “Lower Costs Through Better Health”.